Sasha Jovanovic
3 min read
Trulieve Cannabis has seen its share price move sharply in recent years, which puts a spotlight on whether the cash the business can produce really lines up with what investors are paying today. With a Discounted Cash Flow (DCF) estimate available, the central question is how well that intrinsic value compares with the current market enthusiasm around the stock.
-
Over the past year the stock has gained 98.7%, which raises a clear question about whether that kind of move is supported by the cash the business is expected to generate.
-
The company’s long term story now depends on how efficiently it can turn its operations into consistent free cash flow and how much reinvestment is needed to sustain the business, since both factors directly shape any intrinsic value estimate.
-
If you’d rather focus on sales, this one’s for you. See what Trulieve Cannabis’s 1.8x P/S says about the price.
The issue now is whether Trulieve Cannabis’s recent share price level is adequately backed by the cash flows implied in its intrinsic value estimate.
To see how Trulieve Cannabis compares with other cash flow focused opportunities, view it alongside 35 high quality undervalued stocks
Is Trulieve Cannabis a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) model here looks at what Trulieve Cannabis might return to shareholders in cash over time. On the latest twelve month figures the group produced free cash flow of about $140.5 million, and the forecast path in the model assumes that cash generation grows at a relatively modest pace rather than surging or shrinking sharply.
Those projected cash flows are then discounted back to today and compared with the current share price of $10.33. Because the DCF outcome comes in substantially above that price, the model implies the market is treating Trulieve Cannabis’s future cash stream cautiously and not giving full credit to the projected steady expansion in free cash flow. Find out what Trulieve Cannabis could be worth using our Discounted Cash Flow (DCF) estimate.
The Trulieve Cannabis Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives pick up where the valuation puzzle around Trulieve Cannabis leaves off by spelling out which paths for growth, margins and earnings would need to hold for the stock to be worth materially more or less than today’s market price. Each narrative treats Trulieve Cannabis’ fair value as a thesis you can track over time rather than a one off snapshot, and they sit on the company’s Community page.
One of the top narratives on Trulieve Cannabis: 43% undervalued